Parecer de pré-exame
#6.23
03/28/2023
RPI 2725
Application data
Number
112020021976Type
Filing
Publication
PCT
CN2019085342 The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.
Latest action published by the INPI: 03/28/2023. We update with every new RPI gazette, published weekly.
Applicants
TIANJIN HEMAY PHARMACEUTICAL CO., LTD.
CN
Inventors
D. Z. (pessoa física)
CN
L. W. (pessoa física)
CN
Y. C. (pessoa física)
CN
IPC Classification
Priority claims
CN
201810407741.X · 05/02/2018
Abstract
A invenção refere-se à forma de cristal II do composto (S)-N-[5-[1-(3-etóxi-4-metoxifenil))-2-(metilsulfonil)etil]-4,6-dioxo-5,6-di-hidro-4H-tieno[3,4-c]prrol-1-il]acetamida.
Publications in the Brazilian Industrial Property Gazette (RPI).
#6.23
03/28/2023
RPI 2725
#15.35
12/14/2021
RPI 2658
#1.3
01/26/2021
RPI 2612
#1.1
11/10/2020
RPI 2601
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.